178 related articles for article (PubMed ID: 30916482)
1. Rapid free thiol rebound is a physiological response following cold-induced vasoconstriction in healthy humans, primary Raynaud and systemic sclerosis.
Abdulle AE; van Roon AM; Smit AJ; Pasch A; van Meurs M; Bootsma H; Bakker SJL; Said MY; Fernandez BO; Feelisch M; van Goor H; Mulder DJ
Physiol Rep; 2019 Mar; 7(6):e14017. PubMed ID: 30916482
[TBL] [Abstract][Full Text] [Related]
2. Plasma urotensin II levels in primary Raynaud's phenomenon and systemic sclerosis.
Gözel N; Karataş A; Yardım M; Kınacı MS; Ulu R; Demircan F; Kılınç F; Öz B; Dönder E; Aydın S; Koca SS
Turk J Med Sci; 2017 Dec; 47(6):1687-1692. PubMed ID: 29306224
[TBL] [Abstract][Full Text] [Related]
3. Circulating nerve growth factor in primary and secondary Raynaud's syndrome - results of a pilot study.
Klein-Weigel P; Gutsche-Petrak B; Humpel C; Riemekasten G; Ivanov S; Heidrich H
Vasa; 2009 Feb; 38(1):39-45. PubMed ID: 19229802
[TBL] [Abstract][Full Text] [Related]
4. Assessing recovery after cold challenge and thumb involvement can help to rule out systemic sclerosis in patients presenting with Raynaud's phenomenon.
van Roon AM; van Roon AM; Stel AJ; Bootsma H; Smit AJ; Mulder DJ
Scand J Rheumatol; 2020 Mar; 49(2):137-140. PubMed ID: 31637927
[No Abstract] [Full Text] [Related]
5. Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis.
Della Rossa A; Cazzato M; d'Ascanio A; Tavoni A; Bencivelli W; Pepe P; Mosca M; Baldini C; Rossi M; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):109-14. PubMed ID: 23073231
[TBL] [Abstract][Full Text] [Related]
6. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
[TBL] [Abstract][Full Text] [Related]
7. Choroidal impairment and macular thinning in patients with systemic sclerosis: the acute study.
Ingegnoli F; Gualtierotti R; Pierro L; Del Turco C; Miserocchi E; Schioppo T; Meroni PL; ;
Microvasc Res; 2015 Jan; 97():31-6. PubMed ID: 25262916
[TBL] [Abstract][Full Text] [Related]
8. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
[TBL] [Abstract][Full Text] [Related]
9. Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenon.
Kundu D; Abraham D; Black CM; Denton CP; Bruckdorfer KR
Vascul Pharmacol; 2014 Dec; 63(3):178-81. PubMed ID: 25446164
[TBL] [Abstract][Full Text] [Related]
10. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE
Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
[TBL] [Abstract][Full Text] [Related]
11. Novel photoplethysmography cardiovascular assessments in patients with Raynaud's phenomenon and systemic sclerosis: a pilot study.
McKay ND; Griffiths B; Di Maria C; Hedley S; Murray A; Allen J
Rheumatology (Oxford); 2014 Oct; 53(10):1855-63. PubMed ID: 24850874
[TBL] [Abstract][Full Text] [Related]
12. Cooling-induced contraction and protein tyrosine kinase activity of isolated arterioles in secondary Raynaud's phenomenon.
Furspan PB; Chatterjee S; Mayes MD; Freedman RR
Rheumatology (Oxford); 2005 Apr; 44(4):488-94. PubMed ID: 15695304
[TBL] [Abstract][Full Text] [Related]
13. Abnormal amplitude and kinetics of digital postocclusive reactive hyperemia in systemic sclerosis.
Gaillard-Bigot F; Roustit M; Blaise S; Gabin M; Cracowski C; Seinturier C; Imbert B; Carpentier P; Cracowski JL
Microvasc Res; 2014 Jul; 94():90-5. PubMed ID: 24990822
[TBL] [Abstract][Full Text] [Related]
14. Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis.
Herrick AL; Rieley F; Schofield D; Hollis S; Braganza JM; Jayson MI
J Rheumatol; 1994 Aug; 21(8):1477-83. PubMed ID: 7983650
[TBL] [Abstract][Full Text] [Related]
15. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
O'Reilly D; Taylor L; el-Hadidy K; Jayson MI
Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594
[TBL] [Abstract][Full Text] [Related]
16. Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis.
Bukhari M; Herrick AL; Moore T; Manning J; Jayson MI
Br J Rheumatol; 1996 Nov; 35(11):1127-31. PubMed ID: 8948300
[TBL] [Abstract][Full Text] [Related]
17. Neuronal regulators and vascular dysfunction in Raynaud's phenomenon and systemic sclerosis.
Fonseca C; Abraham D; Ponticos M
Curr Vasc Pharmacol; 2009 Jan; 7(1):34-9. PubMed ID: 19149638
[TBL] [Abstract][Full Text] [Related]
18. Automated structure and flow measurement - a promising tool in nailfold capillaroscopy.
Berks M; Dinsdale G; Murray A; Moore T; Manning J; Taylor C; Herrick AL
Microvasc Res; 2018 Jul; 118():173-177. PubMed ID: 29605552
[TBL] [Abstract][Full Text] [Related]
19. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon.
Zamora MR; O'Brien RF; Rutherford RB; Weil JV
Lancet; 1990 Nov; 336(8724):1144-7. PubMed ID: 1978025
[TBL] [Abstract][Full Text] [Related]
20. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
Seibold JR; Harris JN
J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
